Intrexon Corporation (XON) was a big mover last session, with shares rising nearly 9% on the day. The move came on solid volume too, with far more shares changing hands than in a normal session. This reverses the recent trend of Intrexon, as the stock is now down over 14% in the past one-month time frame.
This biotechnology company saw one positive estimate revision in the last 30 days and its Zacks Consensus Estimate also moved higher over the same time frame. This implies that Intrexon holds potential for more solid trading going forward. So make sure to keep an eye on this stock to see if Friday’s rally can convert into greater strength down the road.
Intrexon currently has a Zacks Rank #4 (Sell) while its Earnings ESP is negative.
Some better-ranked stocks worth considering in the Healthcare sector include BG Medicine, Inc. (BGMD), ICON Public Limited Company (ICLR) and Charles River Laboratories International, Inc. (CRL). All these stocks carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment